Your browser doesn't support javascript.
loading
Addendum: A case report of androgen receptor inhibitor therapy in recurrent high-grade serous ovarian cancer.
Limaye, Sewanti; Kumar, Prashant; Pragya, Ramya; Sambath, Janani; Patil, Darshana; Srinivasan, Ajay; Apurva, Sachin; Srivastava, Navin; Patil, Sanket; Patil, Revati; Datta, Vineet; Akolkar, Dadasaheb; Datar, Rajan.
Afiliação
  • Limaye S; Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute, Mumbai, Maharashtra, India.
  • Kumar P; Datar Cancer Genetics Limited, Nasik, Maharashtra, India.
  • Pragya R; Institute of Bioinformatics, International Technology Park, Bangalore, Karnataka, India.
  • Sambath J; Manipal Academy of Higher Education, Manipal, Karnataka, India.
  • Patil D; Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute, Mumbai, Maharashtra, India.
  • Srinivasan A; Institute of Bioinformatics, International Technology Park, Bangalore, Karnataka, India.
  • Apurva S; Manipal Academy of Higher Education, Manipal, Karnataka, India.
  • Srivastava N; Datar Cancer Genetics Limited, Nasik, Maharashtra, India.
  • Patil S; Datar Cancer Genetics Limited, Nasik, Maharashtra, India.
  • Patil R; Datar Cancer Genetics Limited, Nasik, Maharashtra, India.
  • Datta V; Datar Cancer Genetics Limited, Nasik, Maharashtra, India.
  • Akolkar D; Datar Cancer Genetics Limited, Nasik, Maharashtra, India.
  • Datar R; Datar Cancer Genetics Limited, Nasik, Maharashtra, India.
Oncotarget ; 13: 982, 2022 08 04.
Article em En | MEDLINE | ID: mdl-36455294

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Oncotarget Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Índia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Oncotarget Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Índia